This is an official Canadian Stroke Consortium (CSC) - StrokeFM Podcast episode: Neuroprotection and stroke care
What does the future hold? Where are we coming from and where are we going? These and other exciting topics of discussion in conversation with Dr. Michael Hill (Calgary Stroke Program) as we chat about ESCAPE NA1 and ESCAPE NEXT. ESCAPE-NEXT is a multi-centre, randomized, double-blinded, placebo-controlled, parallel Group, single-dose trial designed to determine the efficacy and safety of Nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis. This is an official CSC Podcast episode (Season 2, Episode 8). As usual, see our Disclaimer about this educational podcast.
Podden och tillhörande omslagsbild på den här sidan tillhör
Stroke FM. Innehållet i podden är skapat av Stroke FM och inte av,
eller tillsammans med, Poddtoppen.
